Literature DB >> 26842301

Late-onset disease is associated with a mild phenotype in children with familial Mediterranean fever.

Semanur Özdel1, Z Birsin Özçakar1, Seda Şahin Kunt1, Atilla H Elhan2, Fatoş Yalçınkaya3,4.   

Abstract

Familial Mediterranean fever (FMF) is an autosomal recessive disease, characterised by recurrent, self-limited attacks of fever with serositis. Recently, it was shown that patients with early disease onset during childhood period had more severe disease. The aim of this study was to describe the demographic, clinical and genetic features of FMF patients who had late-onset disease during childhood period and to compare them to those with earlier onset patients. Files of patients who had been seen in our department between January 2013 and January 2014 were retrospectively evaluated. Patients were divided into two groups according to age of disease onset (group I, ≤8 years; group II, >8 years), and clinical findings were compared between the two groups. The study group comprised 317 FMF patients. There were 267 patients in group I and 50 patients in Group II. Median attack frequency was 24/year in group I and 12/year in group II (p < 0.05). Fever and M694V homozygosity were less frequently detected in group II (p = 0.003 and p = 0.022). Median delay in diagnosis was 24 months in group I and 12 months in group II (p = 0.002). Disease severity scores and final colchicine dosages were lower in group II (p < 0.001 and p = 0.003). Only a small number of FMF patients had disease onset at older ages in childhood period. It seems that FMF patients with late-onset disease have milder illness. However, more readily expression of their clinical findings in older ages yields earlier diagnosis in this group.

Entities:  

Keywords:  Disease severity; Familial Mediterranean fever; Late onset; Paediatric

Mesh:

Substances:

Year:  2016        PMID: 26842301     DOI: 10.1007/s10067-016-3196-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

1.  Characteristics of patients with adult-onset familial Mediterranean fever in Turkey: analysis of 401 cases.

Authors:  M Sayarlioglu; A Cefle; M Inanc; S Kamali; E Dalkilic; A Gul; L Ocal; O Aral; M Konice
Journal:  Int J Clin Pract       Date:  2005-02       Impact factor: 2.503

2.  Familial Mediterranean fever in small children in Turkey.

Authors:  Fatos Yalcinkaya; Z Birsin Ozcakar; Murat Tanyildiz; Atilla H Elhan
Journal:  Clin Exp Rheumatol       Date:  2011-09-27       Impact factor: 4.473

3.  Can colchicine response be predicted in familial Mediterranean fever patients?

Authors:  Zeynep Birsin Özçakar; Atilla H Elhan; Fatoş Yalçınkaya
Journal:  Rheumatology (Oxford)       Date:  2014-04-24       Impact factor: 7.580

4.  Familial Mediterranean fever in children: the expanded clinical profile.

Authors:  H A Majeed; M Rawashdeh; H el-Shanti; H Qubain; N Khuri-Bulos; H M Shahin
Journal:  QJM       Date:  1999-06

Review 5.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

6.  Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish population.

Authors:  E Yilmaz; S Ozen; B Balci; A Duzova; R Topaloglu; N Besbas; U Saatci; A Bakkaloglu; M Ozguc
Journal:  Eur J Hum Genet       Date:  2001-07       Impact factor: 4.246

Review 7.  Diagnostic and treatment concerns in familial Mediterranean fever.

Authors:  A Livneh; P Langevitz
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  2000-09       Impact factor: 4.098

8.  Late-onset familial Mediterranean fever (FMF): a subset with distinct clinical, demographic, and molecular genetic characteristics.

Authors:  N Tamir; P Langevitz; D Zemer; E Pras; Y Shinar; S Padeh; N Zaks; M Pras; A Livneh
Journal:  Am J Med Genet       Date:  1999-11-05

9.  A new set of criteria for the diagnosis of familial Mediterranean fever in childhood.

Authors:  Fatos Yalçinkaya; Seza Ozen; Zeynep Birsin Ozçakar; Nuray Aktay; Nilgün Cakar; Ali Düzova; Ozgür Kasapçopur; Atilla H Elhan; Beyza Doganay; Mesiha Ekim; Nazli Kara; Nermin Uncu; Aysin Bakkaloglu
Journal:  Rheumatology (Oxford)       Date:  2009-02-04       Impact factor: 7.580

10.  Adult-onset familial mediterranean Fever in northwestern iran; clinical feature and treatment outcome.

Authors:  H Nobakht; F Zamani; H Ajdarkosh; Z Mohamadzadeh; Sm Fereshtehnejad; M Nassaji
Journal:  Middle East J Dig Dis       Date:  2011-03
View more
  6 in total

1.  Evaluation of subclinical inflammation in familial Mediterranean fever patients: relations with mutation types and attack status: a retrospective study.

Authors:  Fatih Mehmet Kelesoglu; Erhan Aygun; Nazli Kubra Okumus; Ayşenur Ersoy; Edanur Karapınar; Nesibe Saglam; Nur Gokce Aydın; Beyza Betul Senay; Sumeyye Gonultas; Elif Sarisik; Melike Zeynep Can; Sirin Atay; Dilruba Basbug; Feyza Kubra Tiryaki; Sena Ozer; Rana Berru Durmus; Fatih Orem; Tugrul Atay; Ahmet Acar; Yasin Yilmaz; Seyma Kaya; Aylin Ciftkaya; Zeynep Sarac; Cagri Can Makar; Basak Saracoglu; Gafur Dogdu; Rukiye Eker Omeroglu
Journal:  Clin Rheumatol       Date:  2016-04-23       Impact factor: 2.980

2.  Is late-onset disease or the lower rate of M694V mutations associated with the mild disease phenotype?

Authors:  Fatih Mehmet Kelesoglu; Gafur Dogdu; Elif Yildirim; Burcu Sena Gunaydin; Rukiye Eker Omeroglu; Tugrul Atay; Fatih Orem; Fatih M Kelesoglu
Journal:  Clin Rheumatol       Date:  2016-03-23       Impact factor: 2.980

3.  Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections.

Authors:  Mustafa Çakan; Nuray Aktay Ayaz; Gonca Keskindemirci; Şerife Gül Karadağ; Ayşe Tanatar; Hafize Emine Sönmez
Journal:  Clin Rheumatol       Date:  2019-09-04       Impact factor: 2.980

4.  Familial Mediterranean Fever with Neonatal Onset: Case Report.

Authors:  Kübra Arslan; Serdar Ümit Sarici; Gonca Kolukisa; Demet Altun
Journal:  Case Rep Pediatr       Date:  2020-12-14

5.  Real-Life Data From the Largest Pediatric Familial Mediterranean Fever Cohort.

Authors:  Kübra Öztürk; Taner Coşkuner; Esra Baglan; Hafize Emine Sönmez; Gülçin Otar Yener; Figen Çakmak; Fatma Gül Demirkan; Ayşe Tanatar; Serife Gül Karadag; Semanur Ozdel; Ferhat Demir; Mustafa Çakan; Nuray Aktay Ayaz; Betül Sözeri
Journal:  Front Pediatr       Date:  2022-01-20       Impact factor: 3.418

6.  [Results of the systematic literature search as basis for the "Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine" of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].

Authors:  T Sahr; U Kiltz; C Weseloh; T Kallinich; J Braun
Journal:  Z Rheumatol       Date:  2020-09-30       Impact factor: 1.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.